Tether is collaborating with Shiga to create self-custody financial products that enable users and institutions in Africa and the Gulf Cooperation Council region to hold and transfer digital assets like USD₮, Bitcoin, and Tether Gold. These products use Tether's open-source Wallet Development Kit and target individuals, businesses, banks, and fintech firms. Shiga is also nearing approval for a digital-asset intermediary license in Nigeria, which will support broader adoption and regulatory compliance in the region.
Tether and Shiga's expansion of self-custody financial products across Africa and the Gulf is noted alongside Pluang's cryptocurrency market data. For readers following digital assets, here is Pluang's market snapshot as of Sep 28, 2026 19:21 WIB: out of 50 major cryptocurrencies, 11 rose and 38 fell today. Notable movers include AXS at Rp19.883 with 98% sell order activity, ATOM at Rp31.933 with 80% sell orders, and SNX at Rp4.428 with 93% buy orders and a typical hold time of 70 days on Pluang.
Grail's stock surged 55% in one week following a positive FDA advisory committee vote on its Galleri multi-cancer early detection test, which was deemed safe and beneficial. Analyst Kyle Mikson raised the price target from $80 to $150, reflecting str...
Roblox stock fell 6% following Jefferies' downgrade to Underperform and a price target cut to $38, citing concerns over overly optimistic bookings outlook and slower user growth in the US and Canada. This downgrade contrasts with steady performance i...
Geely Holding Group has acquired a 30% stake in Nio Power, the battery swapping and charging unit of Nio, valuing the business at about RMB16 billion. This investment marks a significant external validation of Nio's battery swapping network, a key as...
CoreWeave reported strong Q2 results with significant scale and margin improvements, supported by a $104.2 billion backlog driven by demand from hyperscalers exceeding supply. The company raised its 2026 revenue guidance to $12.4–$13.2 billion, expec...
Tiziana Life Sciences has dosed the first three patients in a Phase 2a trial testing foralumab, a nasal spray antibody, for treating early-stage ALS. The Healey ALS MyMatch BANYAN trial will enroll 44 patients to evaluate safety, tolerability, and im...
